Stephen A. Carlino
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A case report of high-titer FVIII inhibitor development after AAV-mediated gene therapy in hemophilia A.
Journal: Blood vessels, thrombosis & hemostasis
Published: January 09, 2026
Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients.
Journal: Research and practice in thrombosis and haemostasis
Published: October 22, 2024
Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levels.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 30, 2024
Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels.
Journal: Thrombosis research
Published: March 31, 2022
Mixing study to diagnose heparin-resistance caused by functional antithrombin deficiency.
Journal: International journal of laboratory hematology
Published: August 26, 2021
Update on diagnostic testing for platelet function disorders: What is practical and useful?
Journal: International journal of laboratory hematology
Published: December 21, 2018
Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
Journal: International journal of laboratory hematology
Published: January 17, 2014
Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder.
Journal: Thrombosis and haemostasis
Published: October 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026